Expert Panel Examines Biosimilar Pathway
The FDA does not usually require animalstudies for biosimilars; therefore, the process can move directly to pharmacokinetic and pharmacodynamic studies.
Best Practices for Transitioning From IV to SQ Dosing
According to the experts, having well thought-out administration procedures is imperative to providing a smooth transition process for the health care team.
Ixekizumab Superior to Adalimumab in Sustained Joint, Skin Improvement in PsA
The phase 3b/4 SPIRIT head-to-head study evaluated ixekizumab (Taltz) versus adalimumab (Humira) in psoriatic arthritis.
Midazolam Nasal Spray Treatment for Seizure Clusters to be Available in December
Approved by the FDA in May 2019, midazolam nasal spray CIV (Nayzilam, UCB) is the first nasal rescue treatment for seizure clusters in the United States.
Study Finds Live Zoster Vaccine Safe, Effective in Patients Taking TNF Inhibitors
The study evaluated the safety and efficacy of a live, attenuated zoster vaccine patients receiving tumor necrosis factor inhibitor therapies for various indications.
FDA Approves Acalabrutinib for CLL Indication
Under a new international collaboration, the FDA has granted supplemental approval to acalabrutinib (Calquence, AstraZeneca) for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic leukemia.
Study: Ixekizumab Improves Symptoms of Non-Radiographic Axial Spondyloarthritis
The COAST-X study evaluated ixekizumab (Taltz, Eli Lilly) in patients with non-radiographic axial spondyloarthritis.
Teva to Resume Production of Vincristine After Widespread Shortages
With vincristine in short supply, Teva will resume production of the chemotherapy agent following its previous decision to remove the product from the market.
Study: Rituximab Superior to Mycophenolate Mofetil as Pemphigus Vulgaris Treatment
Findings from a phase 3 study reinforced the safety and efficacy of rituximab (Rituxan, Genentech) as a treatment for patients with pemphigus vulgaris.
Reintroduced Legislation Seeks to Expand Seniors’ Pharmacy Choice, Access
The Ensuring Seniors Access to Local Pharmacies Act, which was recently reintroduced, would allow more “preferred” pharmacies in medically underserved areas.
FDA Report: Changes in Marketplace Needed to Mitigate Drug Shortages
The FDA Drug Shortages Task Force addressed the root causes of drug shortages and proposed potential solutions.
AscellaHealth Brings Innovative, Tailored PBM Services to Specialty Pharmacy
In today's evolving health care and reimbursement landscape, specialty pharmacies are facing pressure to adopt more efficient and cost-effective solutions.
A Review of Dupilumab
Dupixent is the first FDA-approved medicine for adults with chronic rhinosinusitis with nasal polyposis and the only approved therapy shown to shrink nasal polyp size and improve the signs and symptoms of the associated chronic rhinosinusitis.
Vincristine Drug Shortage Stirs Concern for Impact on Pediatric Patients with Cancer
Limited supply of chemotherapy agent that treats several pediatric cancers may lead to rationing of doses.
Medication Therapy Choice, Management Strategies in Inflammatory Diseases
Specialty pharmacists a crucial role in optimizing the treatment of patients with inflammatory diseases, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS).
Managing Compliance in Specialty Pharmacy From a Regulatory, Accreditation Perspective
In an ever-changing regulatory health care landscape, specialty pharmacies must continuously ensure they are adapting to evolving industry standards.
Drug Pricing Reform: What’s Happening Now and What’s to Come
More than a year after the Trump administration’s drug pricing blueprint was released, reform has remained at the forefront of many discussions involving health care legislation.
Andy Slavitt Addresses High Health Care Costs During NASP Keynote Speech
For many Americans living in today’s health care environment, cost is a dominant concern when a serious disease is diagnosed.
ISOPP Releases Global Position Statement on Oncology Biosimilar Use
The International Society of Oncology Pharmacy Practitioners global position on oncology biosimilar use covers regulation and evaluation, implementation, education, and monitoring.
New Insight into How ART Alters the HIV Reservoir May Lead to Better Treatments
New study provides evidence that the use of antiretroviral therapy alters the formation or stabilization of HIV latent reservoirs.
Study: Long-Term Dupilumab Safe and Effective in Adolescents with Atopic Dermatitis
Long-term treatment with dupilumab showed benefit in adolescents with atopic dermatitis comparable with the treatment’s effect in adults.
Immunotherapy Toxicity: Strategies for Monitoring, Treating Adverse Events
A session at the ESMO Congress 2019 highlighted potential prevention and treatment strategies for life-threatening immunotherapy toxicities in patients with cancer.
Diabetes Associated with Increased Risk of Non-Hodgkin Lymphoma
Patients with diabetes demonstrated a higher likelihood of developing non-Hodgkin lymphoma than those without diabetes, especially among men.
The Oncology Drug Pathway: Getting Medications From the Pharmacy to the Patient
Despite advances in cancer care, patients typically face obstacles to treatment.
New Direction in Chronic Inflammation Treatment Development
Research demonstrates a new direction in cell signaling and treatment for chronic inflammatory diseases such as psoriasis, asthma, and HIV.
Rituximab Biosimilar Candidate Shows Clinical Equivalence in Non-Hodgkin Lymphoma
ABP 798, a biosimilar candidate to rituximab (Rituxan), demonstrated clinical equivalence in a study of patients with non-Hodgkin lymphoma.
Provider Partnerships: The Leading Strategy for Health System Specialty Pharmacy Success
An upcoming webinar by Trellis Rx on Wednesday, September 18, will offer a firsthand look into how to accelerate the growth of your specialty pharmacy program by building strong provider partnerships.
Does Your Data Tell a Story: Translating Data Reporting in Specialty Pharmacy
In an ideal world, how would you hypothesize that technology might be able to solve all of your problems?
Overcoming Funding, Staffing Challenges Amid Rapid Growth in Health System Specialty Pharmacy
With rapid growth, health system specialty pharmacies are more than likely to run into several operational pain points.
Can You Scale For It: Considerations in Health-System Specialty Pharmacy Growth
With specialty pharmacy emerging as the fastest growing segment of the pharmacy industry, health systems have to address a key question: can you scale for it?
2 Clarke Drive Cranbury, NJ 08512